Meropenem

Treatment for Invasive Non-typhoidal Salmonella (iNTS)

Typical Dosage: 1g IV every 8 hours

Effectiveness
95%
Safety Score
65%
Clinical Trials
80
Participants
8K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
1g IV every 8 hours
Time to Effect
1-2 days
Treatment Duration
7-14 days
Evidence Quality
MODERATE
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,000
Monitoring:$1,000
Side Effect Mgmt:$100
Total Annual:$3,100
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.25
Outcome-Based Costs
Cost per Responder
$3,263
Cost per Remission
$3,263
Meropenem Outcomes

for Invasive Non-typhoidal Salmonella (iNTS)

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
Diarrhea
+4%
Nausea/Vomiting
+3%
Injection site reactions
+2%
Seizures
+0.1%

Sources:

nih.gov
researchgate.net
asm.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov